Renal Sympathetic Denervation after Renal Transplantation Study - I
Phase 4
Withdrawn
- Conditions
- Hypertension10057166
- Registration Number
- NL-OMON37506
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Hypertension despite 2 or more anti-hypertensive drugs
Functioning transplant kidney in situ
Exclusion Criteria
Renal artery stenosis of native of transplant reanl arteries
Primary hyperaldosteronisme
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Procedural success (4-8 ablation per renal artery) without adverse events<br /><br>during hospitalization (death, renal artery dissection, renal or peripheral<br /><br>embolisation, major bleeding).<br /><br>Blood pressure reduction at 6 months, by 24-h RR measurement.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Efficacy endpoints: clinical cardiovascular events, systemic and imaging<br /><br>parameters of left ventricular remodelling, laboratory parameters of<br /><br>sympathetic and RAAS activation, laboratory assessment of parameters of<br /><br>cardiovascular fibrosis and gene expression of cardiovascular fibrosis</p><br>